EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protective Effects of Alogliptin AgainstIndomethacin-Induced Gastric Ulcers in Rats

Abdulnaser Aklan, محمد عبدالرحمن الخولاني, حسن المحبشي, عبدالملك ابو دنيا, عبدالله صالح احمد احمد, محمد عبده نعمان عباس

مجلة جامعة صنعاء للطب والعلوم الصحية · 28.06.2026 · 20 (3) · 583-591

DOI: 10.59628/jchm.v20i3.2767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift مجلة جامعة صنعاء للطب والعلوم الصحية, online erschienen am 28.06.2026. Verfasst von Abdulnaser Aklan und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Notwithstanding the availability of efficacious antiulcer drugs, concerns over their safety have motivated the lookup of alternate or adjunctive therapies. Drug repurposing is a practical, low-risk, and cost-effective approach. Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as alogliptin, have pleiotropic effects beyond glucose regulation, including antioxidant and anti-inflammatory activities, which may protect the gastric mucosa.

Objectives

To evaluate the gastroprotective potential of alogliptin against indomethacin-induced gastric ulcers in rats.

Methods

Albino rats were assigned randomly to four groups (n = 6): normal control, positive control, omeprazole (20 mg/kg), and alogliptin (3 mg/kg). The treatments were administered for eight consecutive days. All pretreatment groups, except the normal control group, received a single oral dose of indomethacin (50 mg/kg) to induce gastric ulceration. The rats were sacrificed after 6 h, and their stomachs were collected for assessment. Gastric juice volume and pH were measured, and gastric tissues were evaluated both macroscopically and microscopically. Antioxidant markers, including GPx, SOD, and MDA, were measured.

Results

Pretreatment with alogliptin significantly reduced ulcer number by 32.1% and severity by 37.9%. GPx and SOD activities were significantly restored by 44% and 43%, respectively. It also significantly decreased MDA levels by 45.6% compared to the positive control group. Histopathology revealed marked preservation of the gastric mucosal architecture, with reduced necrosis and inflammatory cell infiltration.

Conclusion

Alogliptin exhibits gastroprotective effects, likely via antioxidant mechanisms, suggesting its potential as an adjunct therapy for patients at risk of NSAID-induced gastric ulcers, especially in diabetic populations.

Zitieren

APA

Aklan, A., الخولاني, م. ع., المحبشي, ح., دنيا, ع. ا., احمد, ع. ص. ا., & عباس, م. ع. ن. (2026). Protective Effects of Alogliptin AgainstIndomethacin-Induced Gastric Ulcers in Rats. مجلة جامعة صنعاء للطب والعلوم الصحية, 20(3), 583-591. https://doi.org/10.59628/jchm.v20i3.2767

Vancouver

Aklan A, الخولاني مع, المحبشي ح, دنيا عا, احمد عصا, عباس معن. Protective Effects of Alogliptin AgainstIndomethacin-Induced Gastric Ulcers in Rats. مجلة جامعة صنعاء للطب والعلوم الصحية. 2026;20(3):583-591. doi:10.59628/jchm.v20i3.2767

BibTeX
@article{Aklan2026,
  author = {Aklan, Abdulnaser and الخولاني, محمد عبدالرحمن and المحبشي, حسن and دنيا, عبدالملك ابو and احمد, عبدالله صالح احمد and عباس, محمد عبده نعمان},
  title = {Protective Effects of Alogliptin AgainstIndomethacin-Induced Gastric Ulcers in Rats},
  journal = {مجلة جامعة صنعاء للطب والعلوم الصحية},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {583--591},
  doi = {10.59628/jchm.v20i3.2767}
}
Kostenlos starten →